Clinical and Epidemiological Profile of Progressive Supranuclear Palsy in a Colombian Referral Center: A Retrospective Cohort Study
Neurology Research International · 2026-01 · 2026 (1)
DOI: 10.1155/nri/9076106 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Neurology Research International, online erschienen am 29.10.2026. Verfasst von Marcela Henao-Pérez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Cooperativa de Colombia Medellín Colombia ucc.edu.co. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, Universidad Cooperativa de Colombia.
Abstract (Originalsprache)
Background
Progressive supranuclear palsy (PSP) is a rare 4‐repeat tauopathy characterized by marked clinical heterogeneity and frequent diagnostic delay. Epidemiological and phenotypic data from Latin America remain limited. This study aimed to describe the clinical and epidemiological characteristics of PSP in a Colombian referral center and to compare findings by sex and phenotype.
Methods
We retrospectively reviewed PSP cases evaluated at a Colombian neurological referral center from 2013 to 2023. Demographic, clinical, neuroimaging, diagnostic, and treatment‐related variables were extracted from medical records. PSP phenotypes were retrospectively classified and grouped using clinical information from medical records. Period prevalence was estimated using the adult population of Antioquia as the denominator.
Results
Among 152 patients, 53.9% were male. Crude period prevalence was 1.8 per 100,000 adults, peaking at 75–84 years. Women were older than men at evaluation, whereas age at symptom onset was similar between sexes. Mean diagnostic delay was approximately 3.5 years. Postural instability was the most frequent presenting symptom. PSP‐Richardson syndrome and PSP‐parkinsonism were the most common phenotypes. MRI was the most frequently requested imaging study, and midbrain atrophy was the most common abnormality. Levodopa/carbidopa was the most frequently prescribed medication, with documented initial response in only a subset of treated patients.
Conclusions
PSP in this Colombian cohort predominantly affected older adults and was characterized by substantial diagnostic delay, marked phenotypic heterogeneity, and predominantly symptomatic treatment. These findings expand the limited Latin American literature and underscore the need for earlier recognition of both typical and atypical PSP presentations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universidad Cooperativa de Colombia Medellín Colombia ucc.edu.co.
- Hospital Neurológico de Colombia Medellín Colombia.
ORCID-Profile: Marcela Henao-Pérez, Diana Carolina López-Medina, Alejandra Arboleda-Ramírez, Zahian Barroso-Barrera, Juan Pablo Londoño-Aristizábal
Förderung
- Bill & Melinda Gates Foundation
- Universidad Cooperativa de Colombia
Zitieren
APA
Henao-Pérez, M., López-Medina, D. C., Arboleda-Ramírez, A., Barroso-Barrera, Z., & Londoño-Aristizábal, J. P. (2026). Clinical and Epidemiological Profile of Progressive Supranuclear Palsy in a Colombian Referral Center: A Retrospective Cohort Study. Neurology Research International, 2026(1). https://doi.org/10.1155/nri/9076106
Vancouver
Henao-Pérez M, López-Medina DC, Arboleda-Ramírez A, Barroso-Barrera Z, Londoño-Aristizábal JP. Clinical and Epidemiological Profile of Progressive Supranuclear Palsy in a Colombian Referral Center: A Retrospective Cohort Study. Neurology Research International. 2026;2026(1). doi:10.1155/nri/9076106
BibTeX
@article{HenaoPrez2026,
author = {Henao-Pérez, Marcela and López-Medina, Diana Carolina and Arboleda-Ramírez, Alejandra and Barroso-Barrera, Zahian and Londoño-Aristizábal, Juan Pablo},
title = {Clinical and Epidemiological Profile of Progressive Supranuclear Palsy in a Colombian Referral Center: A Retrospective Cohort Study},
journal = {Neurology Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/nri/9076106}
}
EUVIMED